The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison

  1. Mateos, M.-V.
  2. San-Miguel, J.
  3. Goldschmidt, H.
  4. Sonneveld, P.
  5. Dimopoulos, M.A.
  6. Heeg, B.
  7. Hashim, M.
  8. Deraedt, W.
  9. Hu, P.
  10. Lam, A.
  11. He, J.
Revista:
Leukemia and Lymphoma

ISSN: 1029-2403 1042-8194

Any de publicació: 2020

Volum: 61

Número: 3

Pàgines: 680-690

Tipus: Article

DOI: 10.1080/10428194.2019.1675881 GOOGLE SCHOLAR

Objectius de Desenvolupament Sostenible